Pentosan polysulfate (Elmiron): in vitro effects on prostate cancer cells regarding cell growth and vascular endothelial growth factor production

American Journal of Surgery

Volumn 192, Issue 5 SPEC. ISS., 2006, Pages 640-643

  Zaslau, Stanley ^a   Sparks, Scott ^a   Riggs, Dale ^a   Jackson, Barbara ^a   Kandzari, Stanley J ^a  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cellular inhibition; Elmiron; Prostate cancer; VEGF

Indexed keywords

ANGIOGENESIS INHIBITOR; PENTOSAN POLYSULFATE; VASCULOTROPIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CELL VIABILITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; STAINING; TUMOR VASCULARIZATION;

EID: 33750288573     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2006.08.008     Document Type: Article

References (11)

1. Jemal A., Siegal R., Ward E., et al. Cancer Statistics, 2006. CA Cancer J Clin 56 (2006) 106-130
2. Schamhart D.H., de Boer E.C., Bevers R.F., et al. Mycrobacterial adherence and BCG treatment of superficial bladder cancer. Prog Clin Biol Res 378 (1992) 75-80
3. Zaslau S., Riggs D.R., Jackson B.J., et al. In vitro effects of pentosan polysulfate against malignant breast cells. Am J Surg 188 (2004) 589-592
4. Nguyen N.M., Lehr J.E., and Pienta K.J. Pentosan inhibits angiogenesis in vitro and suppresses prostate tumor growth in vivo. Anticancer Res 13 (1993) 2143-2147
5. Marshall J.L., Wellstein A., Rae J., et al. Phase I trial of orally administered pentosan polysulfate in patients with advanced cancer. Clin Cancer Res 3 (1997) 2347-2354
6. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65 (1983) 55-56
7. th ed. (1983), McGraw-Hill, New York
8. Ludbrook J. Multiple comparison procedures updated. Clin Exp Pharmacol Physiol 25 (1998) 1032-1037
9. Brookoff D. The causes and treatment of pain in interstitial cystitis. In: Sant G.R. (Ed). Cystitis (1997), Lippincott-Raven, New York 177-192
10. Pienta K.J., Murphy B.C., Isaacs W.B., et al. Effect of pentosan, a novel cancer chemotherapeutic agent, on prostate cancer cell growth and motility. Prostate 20 (1992) 233-241
11. Yang J., Wu H.F., Qian L.X., et al. Increased expressions of vascular endothelial growth factor (VEGF), VEGF-C and VEGF receptor-3 in prostate cancer tissue are associated with tumor progression. Asian J Androl 8 (2006) 169-175